Mainz Biomed NV | Investor Presentation Deck | 24 slides — playbook

Mainz Biomed NV | Investor Presentation Deck | 24 slides

Mainz Biomed · 2024-01

arc beats above · slides in the middle · loops below · scroll → 2 LOOPS

Deck intelligence map

5

coverage by narrative range · generated from this deck JSON

Narrative range 6 total

Metadata

Components

Metrics

Tools

Frameworks

Beats

Loops

Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits

— 0/1 slides

100% 1/1 slides 100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Solution 1 slides 100% 1/1 slides 100% 1/1 slides · 7 hits

— 0/1 slides

— 0/1 slides

100% 1/1 slides 100% 1/1 slides

— 0/1 slides

Market Size 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits

— 0/1 slides

— 0/1 slides

100% 1/1 slides 100% 1/1 slides

— 0/1 slides

Product 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits

— 0/1 slides

— 0/1 slides

— 0/1 slides

100% 1/1 slides

— 0/1 slides

Team 2 slides 100% 2/2 slides 100% 2/2 slides · 35 hits

— 0/2 slides

50% 1/2 slides

— 0/2 slides

100% 2/2 slides

— 0/2 slides

Slide inventory

24

every slide · same image gating as the playbook

01

front_matter

Open slide detail

02

other

Open slide detail

03

The slide uses a 2x3 grid layout to present key company pillars.summarize

Open slide detail

04

The slide contrasts the company's decentralized approach against centralized CLIA lab competitors.present_solution

Open slide detail

05

The slide uses a minimalist design with a halftone pattern and company branding.transition

Open slide detail

06

Includes a process diagram for the test workflow and product imagery.present_solution

Open slide detailBeat · Product

07

The slide outlines the technical workflow from sample collection to diagnostic output.present_solution

Open slide detailBeat · Solution

08

The slide uses a 3-column layout to categorize achievements by strategic pillar.show_traction

Open slide detail

09

The slide features a minimalist design with a corporate logo and a halftone dot pattern.front_matter

Open slide detail

10

The slide uses a visual timeline/process flow to show disease progression.frame_problem

Open slide detailBeat · ProblemLoop · Cost Of Inaction

11

The slide uses data from a 2022 JNCI study to justify the clinical importance of AA detection sensitivity.argue_timing

Open slide detailLoop · Cost Of Inaction

12

The slide highlights the integration of mRNA and DNA biomarkers into a proprietary algorithm for colorectal cancer (CRC) and advanced adenoma (AA) detection.present_solution

Open slide detail

13

plan_implementation

Open slide detail

14

The table compares two distinct clinical trials (ColoFuture and eAArly DETECT) across key performance metrics.show_traction

Open slide detail

15

The slide uses two scatter plots to benchmark the company against competitors like Guardant Health, CellMax Life, and Cologuard.compare_peers

Open slide detailBeat · Market Size

16

transition

Open slide detail

17

The slide uses a horizontal timeline format to map product milestones against calendar years.plan_implementation

Open slide detail

18

Slide 18 of a pitch deck.plan_implementation

Open slide detail

19

other

Open slide detailBeat · Team

20

The slide uses a grid layout to present 10 advisors, each with a headshot, name, role, and company logo.other

Open slide detailBeat · Team

21

The slide uses a DNA helix as a creative timeline background, reflecting the company's focus on molecular diagnostics.plan_implementation

Open slide detail

22

Includes income statement metrics, balance sheet data, and equity structure.analyze_data

Open slide detail

23

summarize

Open slide detail

24

state_next_steps

Open slide detail